HEmatology and Oncology journal

The Best Treatments to Use After Checkpoint Inhibition in Melanoma

Grant McArthur, MBBS, PhD

H&O  Which patients with melanoma are candidates for checkpoint inhibition? GM  All patients with unresectable metastatic melanoma—stage IV and unresectable stage III disease—are candidates for checkpoint […]

From Recent Issues

Antibody-Drug Conjugates in Breast Cancer

  H&O  What are antibody-drug conjugates (ADCs)? AB  ADCs are drugs that contain an antibody linked to a chemotherapy agent. Accordingly, they have 3 components: an antibody […]

Evolving Standards of Care for Resected Pancreatic Cancer

    Abstract: Pancreatic cancer is a devastating illness, and surgical resection offers the only chance of a cure for patients with the disease. Relatively few […]

Is Precision Medicine Ready for Use in Breast Cancer?

  H&O  How do you define precision medicine? LP  The term precision medicine is often used as shorthand for personalizing or tailoring treatment recommendations to the […]

Supplements

Highlights in Lymphoma From the 2016 American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the 2016 American Society of Hematology Annual Meeting and Exposition December 3-6, 2016 • San Diego, California PLUS  Meeting Abstract […]